论文部分内容阅读
格列吡嗪控释片与二甲双胍联合治疗对2型糖尿病患者腹部脂肪分布的影响UKPDS研究结果显示,二甲双胍MT与磺脲类药物SU在血糖控制方面相当,但MT能更好地减轻体重。中心性肥胖伴随的腹内脂肪增加是尤为有害的。为评估新型(SU)和(MT)对腹部脂肪沉积的影响,Cefalu WT等人进行了一项
Effect of glipizide controlled-release tablets and metformin on abdominal fat distribution in patients with type 2 diabetes UKPDS study showed that metformin MT and sulfonylureas SU in blood glucose control, but MT can better reduce body weight. Increased intra-abdominal fat associated with central obesity is particularly detrimental. To assess the impact of novel (SU) and (MT) on abdominal fat deposition, Cefalu WT et al.